Capstone Therapeutics Receives NASDAQ Notice Temporarily Suspending Minimum Bid Price Rule

TEMPE, Ariz., Oct. 22, 2008 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. ("the Company"), received on August 11, 2008 a letter dated August 8, 2008 from The Nasdaq Stock Market notifying it that for the 30 consecutive business days preceding the date of the letter, the bid price of the Company's common stock had closed below the $1.00 per share minimum bid price required for continued inclusion on The Nasdaq Global Market pursuant to Nasdaq Marketplace Rule 4450(a)(5). This notification had no effect and has no current effect on the listing of the Company's common stock.

Back to news